Longitudinal Study of the Ocular Complications of AIDS. 1. Ocular Diagnoses at Enrollment

Ophthalmology

Volumn 114, Issue 4, 2007, Pages

  Jabs, Douglas A ^a,b   Van Natta, Mark L ^b   Holbrook, Janet T ^b   Kempen, John H ^c   Meinert, Curtis L ^b   Davis, Matthew D ^d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; COHORT ANALYSIS; CONTROLLED STUDY; EYE DISEASE; EYE EXAMINATION; EYE INFECTION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; LABORATORY TEST; LONGITUDINAL STUDY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PREVALENCE; PRIORITY JOURNAL; RETINITIS;

EID: 33947605551     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2006.11.008     Document Type: Article

References (57)

1. Jabs D.A. Ocular manifestations of HIV infection. Trans Am Ophthalmol Soc 93 (1995) 623-683
2. Hoover D.R., Peng Y., Saah A., et al. Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression. Arch Ophthalmol 114 (1996) 821-827
3. Studies of Ocular Complications of AIDS Research Group, AIDS Clinical Trials Group. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial 4: visual outcomes. Ophthalmology 101 (1994) 1250-1261
4. Studies of Ocular Complications of AIDS Research Group, AIDS Clinical Trials Group. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS: the Cytomegalovirus Retreatment Trial. Arch Ophthalmol 114 (1996) 23-33
5. Studies of Ocular Complications of AIDS Research Group, AIDS Clinical Trials Group. MSL-109 adjuvant therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: the Monoclonal Antibody Cytomegalovirus Retinitis Trial. Arch Ophthalmol 115 (1997) 1528-1536
6. Studies of Ocular Complications of AIDS Research Group, AIDS Clinical Trials Group. The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: the Ganciclovir Cidofovir Retinitis Trial. Am J Ophthalmol 131 (2001) 457-467
7. Kaplan J.E., Masur H., and Holmes K.K. Guidelines for preventing opportunistic infections among HIV-infected persons-2002. MMWR Recomm Rep 51 RR-8 (2002) 1-52
8. Kuppermann B.D., Quiceno J.I., Flores-Aguilar M., et al. Intravitreal ganciclovir concentration after intravenous administration in AIDS patients with cytomegalovirus retinitis: implications for therapy. J Infect Dis 168 (1993) 1506-1509
9. Arevalo J.F., Gonzalez C., Capparelli E.V., et al. Intravitreous and plasma concentrations of ganciclovir and foscarnet after intravenous therapy in patients with AIDS and cytomegalovirus therapy in patients with AIDS and cytomegalovirus retinitis. J Infect Dis 172 (1995) 951-956
10. Martin D.F., Parks D.J., Mellow S.D., et al. Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant: a randomized controlled clinical trial. Arch Ophthalmol 112 (1994) 1531-1539
11. Martin D.F., Kupperman B.D., Wolitz R.A., et al. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. N Engl J Med 340 (1999) 1063-1070
12. Studies of Ocular Complications of AIDS Research Group, AIDS Clinical Trials Group. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med 326 (1992) 213-220
13. Studies of Ocular Complications of AIDS (SOCA) Research Group, AIDS Clinical Trials Group (ACTG). Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis: the Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. Am J Ophthalmol 124 (1997) 61-70
14. Holbrook J.T., Davis M.D., Hubbard L.D., et al. Risk factors for advancement of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Arch Ophthalmol 118 (2000) 1196-1204
15. Palella F.J., Delaney K.M., Moorman A.C., et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 338 (1998) 853-860
16. Jabs D.A., and Bartlett J.G. AIDS and ophthalmology: a period of transition. Am J Ophthalmol 124 (1997) 227-233
17. Holtzer C.D., Jacobson M.A., Hadley W.K., et al. Decline in the rate of specific opportunistic infections at San Francisco General Hospital, 1994-1997. AIDS 12 (1998) 1931-1933
18. Jacobson M.A., Stanley H., Holtzer C., et al. Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy. Clin Infect Dis 30 (2000) 231-233
19. Jabs D.A. AIDS and ophthalmology in 2004. Arch Ophthalmol 122 (2004) 1040-1042
20. Komanduri K.V., Viswanathan M.N., Wieder E.D., et al. Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1. Nat Med 4 (1998) 953-956
21. Jabs D.A., Bolton G., Dunn J.P., and Palestine A.G. Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy. Am J Ophthalmol 126 (1998) 817-822
22. Tural C., Romeu J., Sirera G., et al. Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients. J Infect Dis 177 (1998) 1080-1083
23. Macdonald J.C., Torriani F.J., Morse L.S., et al. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy. J Infect Dis 177 (1998) 1182-1187
24. Whitcup S.M., Fortin E., Lindblad A.S., et al. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis. JAMA 282 (1999) 1633-1637
25. Torriani F.J., Freeman W.R., Macdonald J.C., et al. CMV retinitis recurs after stopping treatment in virological and immunological failure of potent antiretroviral therapy. AIDS 14 (2000) 173-180
26. Johnson S.C., Benson C.A., Johnson D.W., and Weinberg A. Recurrences of cytomegalovirus retinitis in a human immunodeficiency virus-infected patient despite potent antiretroviral therapy and apparent immune reconstitution. Clin Infect Dis 32 (2001) 815-819
27. Komanduri K.V., Feinberg J., Hutchins R.K., et al. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis. J Infect Dis 183 (2001) 1285-1289
28. Kirk O., Reiss P., Uberti-Foppa C., et al. Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy. Ann Intern Med 137 (2002) 239-250
29. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 41 RR-17 (1992) 1-19
30. Wu A.W., Coleson L.C., Holbrook J., et al. Measuring visual function and quality of life in patients with cytomegalovirus retinitis: development of a questionnaire. Arch Ophthalmol 114 (1996) 841-847
31. Martin B.K., Kaplin Gilpin A.M., Jabs D.A., et al. Reliability, validity and responsiveness of general and disease-specific quality of life measures in a clinical trial for cytomegalovirus retinitis. J Clin Epidemiol 54 (2001) 376-386
32. Wu A.W., Rubin H.R., Mathews W.C., et al. A heath status questionnaire using 30 items from the Medical Outcomes Study: preliminary validation in persons with early HIV infection. Med Care 29 (1991) 786-798
33. EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 16 (1990) 199-208
34. Jabs D.A., Forman M., Enger C., et al. Comparison of cytomegalovirus loads in plasma and leukocytes of patients with cytomegalovirus retinitis. J Clin Microbiol 37 (1999) 1431-1435
35. Studies of Ocular Complications of AIDS (SOCA) Research Group, AIDS Clinical Trials Group (ACTG). Studies of Ocular Complications of AIDS Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 1. Rationale, design and methods. Control Clin Trials 13 (1992) 22-39
36. Dunn J.P., Yamashita A., Kempen J.H., and Jabs D.A. Retinal vascular occlusion in patients infected with human immunodeficiency virus. Retina 25 (2005) 759-766
37. Altman D.G. Practical Statistics for Medical Research (1991), Chapman and Hall, London 213-215 241-56
38. Table 20: reported cases of HIV infection (not AIDS) for male adults and adolescents, by transmission category and race/ethnicity, cumulative through 2003-41 areas with confidential name-based HIV infection reporting. HIV AIDS Surveill Rep 15 (2003) 20. http://www.cdc.gov/hiv/topics/surveillance/resources/reports/2003report/table20.htm Available at: http://www.cdc.gov/hiv/topics/surveillance/resources/reports/2003report/table20.htm. Accessed November 2, 2006.
39. Kaslow R.A., Ostrow D.C., Detels R., et al. The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol 126 (1987) 310-318
40. Multicenter AIDS Cohort Study. Available at: http://www.statepi.jhsph.edu/macs/macs.html. Accessed October 18, 2006.
41. National Institute of Allergy and Infectious Diseases. HIV infection among gay and bisexual men IX International Conference on AIDS highlights [sic]. Available at: http://www.aegis.com/news/niaid/1993/CDC93048.html. Accessed October 18, 2006.
42. Goedert J.J., Kessler C.M., Aledort L.M., et al. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med 321 (1989) 1141-1148
43. Sterling T.R., Vlahov D., Astemborski J., et al. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. N Engl J Med 344 (2001) 720-725
44. National Institute of Allergy and Infectious Diseases. The Women and Infants Transmission Study. Available at: http://www.niaid.nih.gov/daids/wits.htm. Accessed October 18, 2006.
45. Skurnick J.H., Kennedy C.A., Perez G., et al. Behavioral and demographic risk factors for transmission of human immunodeficiency virus type 1 in heterosexual couples: report from the Heterosexual HIV Transmission Study. Clin Inf Dis 26 (1998) 855-864
46. National Institute of Allergy and Infectious Diseases. NIAID resources for studying HIV/AIDS in women. Available at: http://www.aegis.com/factshts/niaid/1997/niaid97_fact_sheet_reswomen.html. Accessed October 18, 2006.
47. Palella F.J., Baker R.K., Moorman A.C., et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. Acquir Immune Defic Syndr 43 (2006) 27-34
48. Bacon M.C., von Wyl V., Alden C., et al. The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench. Clin Diagn Lab Immunol 12 (2005) 1013-1019
49. Veterans' Aging Cohort Study. Available at: http://www.vacohort.org. Accessed May 13, 2005.
50. Veterans Aging Cohort Study. Recruitment summary VACS/NIAAA Study-weekly report (2006). http://www.vacohort.org/Recruit.html July 7, -week 211. Available at: http://www.vacohort.org/Recruit.html. Accessed November 2, 2006.
51. Miller V., Mocroft A., Reiss P., et al. Relations among CD4 lymphocyte nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA Study. Ann Intern Med 130 (1999) 570-577
52. Phillips A.N., Staszewski S., Weber R., et al. HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. JAMA 286 (2001) 2560-2567
53. Murphy E.L., Collier A.C., Kalish L.A., et al. Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med 135 (2001) 17-26
54. Kovacs A., Schluchter M., Easley K., et al. Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1 infected women. N Engl J Med 341 (1999) 77-84
55. Kuppermann B.D., Petty J.G., Richman D.D., et al. Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol 115 (1993) 575-582
56. Gallant J.E., Moore R.D., Richman D.D., et al. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. J Infect Dis 166 (1992) 1223-1227
57. Pertel P., Hirschtick R., Phair J., et al. Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. J Acquir Immune Defic Syndr 5 (1992) 1069-1074